Stifel Downgrades Medtronic: Growth Delays Impact Outlook

Stifel's Downgrade of Medtronic: Understanding the Context

Stifel, a leading financial services firm, has revised its rating for Medtronic PLC, shifting from a "Buy" to a "Hold" position, with a reduced price target from $100 to $85. This decision is influenced by several factors affecting Medtronic's growth trajectory and competitive edge.